Recruiting
A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers
NCT06805617
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Advanced Salivary Gland Carcinoma, +14 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States